Journals / Erciyes Tıp Dergisi / 2007 / Cilt: 29 - Sayı: 4

Prilocaine-induced methemoglobinemia: Report of two cases and review of literature

Prilokaine bağlı methemoglobinemi iki olgu sunumu ve literatüre bakış

Pages
322–325
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When a newborn presents with cyanosis, which is not associated with respiratory distress, methemoglobinemia should always be suspected, and the use of drugs should be questioned

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Methemoglobinemia is a rare serious hematological disorder, which is one of the causes of cyanosis in newborn, requiring emergency treatment.
📊
Key Findings & Data:Here, we report two cases in newborn with toxic methemoglobinemia associated with prilocain.
💡
Conclusion & Impact:When a newborn presents with cyanosis, which is not associated with respiratory distress, methemoglobinemia should always be suspected, and the use of drugs should be questioned
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Methemoglobinemia is a rare serious hematological disorder, which is one of the causes of cyanosis in newborn, requiring emergency treatment. Here, we report two cases in newborn with toxic methemoglobinemia associated with prilocain. In the first case, EMLA cream had been applied to skin by mistake. In the second patient prilocain had been applied to patient for anesthesia before circumcision. When a newborn presents with cyanosis, which is not associated with respiratory distress, methemoglobinemia should always be suspected, and the use of drugs should be questioned

Özet

Methemoglobinemi, ciddi bir hematolojik hastalıktır. Yenidoğanlarda görülen siyanozun nadir, ancak önemli bir nedenidir. Acil müdahale gerektirir. Burada prilokain kullanımına baglı iki yenidoğan methemoglobinemi vakası sunulmuştur. İlk olguda deriye, EMLA krem yanlışlıkla sürülmüştür. İkinci olguda ise, sünnet öncesi lokal anestezik olarak prilokain kullanılmasına bağlı methemoglobinemi gelişmiştir. Respiratuvar distresle ilişkili olmayan siyanozlu yenidoğanlarda methemoglobinemi ayırıcı tanıda düşünülmeli ve ilaç kullanımı sorgulanmalıdır.

🔖

Cite This Article

KUL, M., ALPAY, F., SARICI, S. Ü., GÜLGÜN, M. (2022). Prilocaine-induced methemoglobinemia: Report of two cases and review of literature. Erciyes Tıp Dergisi, Cilt: 29 - Sayı: 4, 322–325. https://ajindex.com/articles/502756

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. K, Vichinsky E.Hemoglobin Disorder. In: Behrman RE, Kleigman RM, Jenson HB (eds), Nelson Textbook of Pediatrics. Philadelpiha: Saunders 2004, pp 1623-1634. 2.Methemoglobinemia: sudden dyspnea and oxyhemoglobin desaturation after esophagoduodenoscopy. Respir Care 2004; 49:940-942. 3. Methemoglobinemia caused by topical teething preparation: a case report. Scientific World Journal 2004; 4:517-520. 4. Aniline and methanol toxicity after shoe dye ingestion. J Emerg Med 2004; 27:367-369. 5.Methemoglobinemia induced by topical vaginal sulfanilamide cream in a patient with cervical cancer: A case report. Gynecol Oncol 2005; 97:953-956. 6. Benzocaine-induced methemoglobinemia: a condition of which all endoscopists should be aware. Can J Gastroenterol 2004; 18:625-629. 7. Acute methemoglobinemia after endoscopy. J Am Board Fam Pract 2004; 17:227-229. 8. Methemoglobinemia in an infant receiving nitric oxide after the use of eutectic mixture of local anesthetic. J Pediatr 2002; 141:285-286. 9. EMLA-induced methemoglobinemia and systemic topical anesthetic toxicity. J Emerg Med 2004;26:85-88. 10. Metin Aydoğan, Demet Gedikbaşı Toprak, Gülcan Türker, Emine Zengin, Emin Sami Arısoy, Ayşe Sevim Gökalp. Prilokaine bağlı toksik methemoglobinemide intravenöz askorbik asit kullanımı: İki vaka takdimi. Çocuk Sağlığı ve Hastalıkları Dergisi 2005, 48:65-68. 11. Familial idiopathic methemoglobinemia revisited: original cases reveal 2 novel mutations in NADH-cytochrome b5 reductase. Blood 2002; 100:3447-3449.